In this free webinar, learn about the history of direct central nervous system (CNS) administration leading to modern day applications. Attendees will learn about the unique challenges from the investigative site perspective with strategies to mitigate them. The featured speakers will also share key operational and regulatory considerations for neuroscience trials with direct CNS administration.

TORONTO (PRWEB) June 14, 2022

In this free webinar, learn about the history of direct central nervous system (CNS) administration leading to modern day applications. Attendees will learn about the unique challenges from the investigative site perspective with strategies to mitigate them. The featured speakers will also share key operational and regulatory considerations for neuroscience trials with direct CNS administration.

The blood-brain barrier limits central nervous system (CNS) exposure of systemically administered investigational products. Direct local administration to the CNS is not new. However, there continues to be debate around routes of delivery, safety profiles and distribution characteristics. The utilization and accrued knowledge of direct CNS administration techniques is increasing, and these approaches are important for CNS targets. The modern-day application of intraparenchymal, intracerebroventricular and intrathecal delivery in neuroscience trials comes with many clinical, operational and regulatory challenges.

To overcome these challenges and mitigate risks, it is essential to understand common site and operational considerations associated with these methods of drug delivery. Challenges include study set-up, site and investigator-specific training requirements, vendor selection, recruitment considerations and a unique regulatory environment.

Join this webinar to learn about the history of direct CNS administration and how it has led to modern day applications. The featured speakers will discuss unique challenges from the investigative site perspective with strategies to mitigate them. The speakers will also share key operational and regulatory considerations for neuroscience trials with direct CNS administration.

Join neuroscience experts from Medpace, James Vornov, MD, PhD, Vice President, Medical Department; Filipe Rodrigues, MD/MSc, Medical Director; and Kelsey Carter, Clinical Trial Manager, for the live webinar on Thursday, June 30, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Considerations for Neuroscience Trials with Direct Administration to the CNS.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.comFor information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

For the original version on PRWeb visit: https://www.prweb.com/releases/considerations_for_neuroscience_trials_with_direct_administration_to_the_cns_upcoming_webinar_hosted_by_xtalks/prweb18735536.htm

Continued here:
Considerations for Neuroscience Trials with Direct Administration to the CNS, Upcoming Webinar Hosted by Xtalks - Benzinga